1. Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation
    Jianbo Yang et al, 2022, Translational Oncology CrossRef
  2. miR-186 regulates epithelial–mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1
    Liangke Tang et al, 2024, Brazilian Journal of Otorhinolaryngology CrossRef
  3. Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
    Jun Xiong et al, 2023, Discover Oncology CrossRef
  4. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics
    Mengyu Chen et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  5. The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition
    Jing Feng et al, 2022, Cells CrossRef
  6. The role of circRNAs in regulation of drug resistance in ovarian cancer
    Jun Zhan et al, 2023, Frontiers in Genetics CrossRef
  7. Chanling Gao suppresses colorectal cancer via PI3K/Akt/mTOR pathway modulation and enhances quality of survival
    Guo Chen et al, 2024, Environmental Toxicology CrossRef
  8. CircCDK17 promotes the proliferation and metastasis of ovarian cancer cells by sponging miR-22-3p to regulate CD147 expression
    Bin Qu et al, 2024, Carcinogenesis CrossRef
  9. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis
    Dinuo Li et al, 2022, Bioengineered CrossRef
  10. The role and application of transcriptional repressors in cancer treatment
    Miso Park et al, 2023, Archives of Pharmacal Research CrossRef
  11. Non-coding RNAs in gynecologic cancer
    Arezoo Solati et al, 2023, Clinica Chimica Acta CrossRef
  12. Drug resistance in ovarian cancer: from mechanism to clinical trial
    Ling Wang et al, 2024, Molecular Cancer CrossRef
  13. Application Value of Combined Detection of DCE-MRI and Serum Tumor Markers HE4, Ki67, and HK10 in the Diagnosis of Ovarian Cancer
    Quanzhi Wang et al, 2022, Contrast Media & Molecular Imaging CrossRef
  14. Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways
    Nicole E. James et al, 2022, Frontiers in Immunology CrossRef
  15. Therapeutic potential of miRNAs in placental extracellular vesicles in ovarian and endometrial cancer
    Yi Zhang et al, 2023, Human Cell CrossRef
  16. Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer
    Arkadiusz Gajek et al, 2021, Cancers CrossRef
  17. Differential expression of follicular fluid exosomal microRNA in women with diminished ovarian reserve
    Ying Xie et al, 2024, Journal of Assisted Reproduction and Genetics CrossRef
  18. miR-125b-5p, miR-155-3p, and miR-214-5p and Target E2F2 Gene in Oral Squamous Cell Carcinoma
    Karolina Gołąbek et al, 2023, International Journal of Molecular Sciences CrossRef
  19. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer
    Atena Yousefi et al, 2024, Scientific Reports CrossRef
  20. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process
    Yuqi Shi et al, 2024, Experimental Cell Research CrossRef
  21. Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma
    Mohammad Jaber MasodKhooy et al, 2023, Phytotherapy Research CrossRef
  22. Epigenetic regulation of epithelial–mesenchymal transition during cancer development
    Sunisa Yoodee et al, 2023, Epigenetic Regulation of Cancer - Part A CrossRef
  23. Icariside II suppresses the tumorigenesis and development of ovarian cancer by regulating miR‐144‐3p/IGF2R axis
    Donglan Yuan et al, 2022, Drug Development Research CrossRef